Nationwide Real-World Outcomes of Trial Eligible and Trial Ineligible Patients With Metastatic Renal Cell Carcinoma Treated With Nivolumab Plus Ipilimumab. - Jespersen MS; Palshof JAE; Fristrup N; Jensen NV; Henriksen JR; Iversen ABB; Steen SG; Andersen M; Madsen K; Svane IM; Darras AKM (Clinical genitourinary cancer, 2025)